Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €7.58 EUR
Change Today +0.167 / 2.25%
Volume 0.0
7BA On Other Exchanges
New York
EN Paris
As of 3:03 AM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

bioamber inc (7BA) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/10/14 - €10.78
52 Week Low
10/16/14 - €5.99
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BIOAMBER INC (7BA)

bioamber inc (7BA) Related Bloomberg News

View More Bloomberg News

bioamber inc (7BA) Related Businessweek News

No Related Businessweek News Found

bioamber inc (7BA) Details

BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various chemical market customers in the United States. Its proprietary technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into chemicals that are replacements for petroleum-derived chemicals. The company’s bio-succinic acid is used in various applications, including plasticizers, polyurethanes, personal care products, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, and food additives, as well as anti-freeze solutions, coolants solvents, water treatment chemicals, laundry tablets and bath salts, artificial leather products, and foams made with recycled polyethylene terephthalate. Its product pipeline also includes bio-succinic acid derivatives, such as 1, 4 butanediol, gamma-butyrolactone, and succinic acid based polyesters; and C6 building block chemicals comprising adipic acid, caprolactam, and hexamethylenediamine. The company sells its products directly to its customers and commercial partners, as well as indirectly through distributor in the Asia-Pacific region. It has strategic relationships with various companies, including PTTMCC Biochem Company Limited, Vinmar International Ltd., and Mitsubishi Chemical Corporation. The company was formerly known as DNP Green Technology, Inc. and changed its name to BioAmber Inc. in September 2010. BioAmber Inc. is headquartered in Montreal, Canada.

74 Employees
Last Reported Date: 03/16/15

bioamber inc (7BA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $480.1K
Chief Operations Officer
Total Annual Compensation: $270.8K
Executive Vice President
Total Annual Compensation: $319.3K
Chief Commercial Officer
Total Annual Compensation: $298.0K
Chief Technology Officer
Total Annual Compensation: $320.0K
Compensation as of Fiscal Year 2014.

bioamber inc (7BA) Key Developments

BioAmber Inc. Presents at ROTH Cleantech Day, Jun-25-2015

BioAmber Inc. Presents at ROTH Cleantech Day, Jun-25-2015 . Venue: The Dorchester, 53 Park Lane, Mayfair, London, W1K 1QA, United Kingdom.

BioAmber Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

BioAmber Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company’s product sales were $367,000 against $351,000 a year ago. Operating loss was $8,460,000 against $7,501,000 a year ago. Loss before income taxes was $8,935,000 against $19,927,000 a year ago. Net loss attributable to the company shareholders was $8,258,000 or $0.38 per basic share against $19,911,000 or $1.07 per basic share a year ago. Net cash used in operating activities was $5,923,000 against $4,867,000 a year ago. Acquisition of property and equipment was $29,055,000 against $12,731,000 a year ago. Adjusted net loss attributable to the company shareholders was $8,578,000 or $0.39 per basic share against $8,311,000 or $0.45 per basic share a year ago.

Bayer MaterialScience Selects BioAmber as Supplier for New Product Line

BioAmber Inc. has been chosen by Bayer MaterialScience as the supplier of bio-succinic acid used to produce a new range of innovative, bio-based polyurethanes for textile applications that Bayer MaterialScience has begun commercializing. Bayer MaterialScience has launched IMPRANIL® eco, a series of bio-based waterborne polyurethane dispersions with renewable content that reaches as high as 65%. IMPRANIL® eco has been developed to address the textile needs of the sportswear/footwear, automotive and fashion industries. IMPRANIL® eco enables manufacturers to produce synthetic materials and coated fabrics with a high content of renewable materials in every layer, with performance that matches the high level of conventional products, and the bio-based raw materials can be used without reformulation.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
7BA:GR €7.58 EUR +0.167

7BA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 7BA.
View Industry Companies

Industry Analysis


Industry Average

Valuation 7BA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 120.4x
Price/Book 3.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 84.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOAMBER INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at